Tag: drug company recall
Octreoscan Test for Carcinoid & NET Patients Currently on Hold in U.S. and Canada
February 4, 2010
Due to a voluntary recall by the drug company Covidien, the Octreoscan Kit using Indium In-111 pentetreotide is not available at the present time in the United States or Canada. This means that carcinoid and neuroendocrine tumor patients cannot have…
READ MORE